Cargando…

A Point-of-Care Interactive Decision Tool Reveals Variance Between Clinicians and Experts in Selecting Among GLP-1 RAs in T2D

Background: T2D management is shifting toward treating patients with therapies that align with their level of CV and end-organ risk. To this end, evidence-based guidelines now recommend glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for both glycemic and extraglycemic benefits. The great spee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwartz, Zachary, Mir-Hudgeons, Kiran, Roc, Anne, Zimmerman, Robert S, Peters, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089797/ http://dx.doi.org/10.1210/jendso/bvab048.949

Ejemplares similares

SAT-132 Improvements Seen Among Clinicians Post-CME Related to Second-Line T2D Therapy
por: Larkin, Amy, et al.
Publicado: (2019)

Management of Late Dumping Syndrome Induced Hypoglycemia With GLP-1R Agonist
por: Shaghouli, Amna Ali, et al.
Publicado: (2021)

SUN-148 Are Glp Analogues Superior For Diabetes And Weight Control In Patients On Antidepressant Medications?
por: Azim, Salman, et al.
Publicado: (2019)

MON-666 Glucokinase Within the Hypothalamic Paraventricular Nucleus Is Important in GLP-1 Release
por: Ratnasabapathy, Risheka
Publicado: (2020)

MON-LB028 Comparing Cardiovascular Effects of GLP-1 Agonists in a Real World Setting
por: Wallia, Amisha, et al.
Publicado: (2019)

Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer? A Systematic Review and Meta-Analysis
por: Piccoli, Giovana Fagundes, et al.
Publicado: (2021)

MON-646 Novel Use of GLP-1 Receptor Agonist Therapy in MODY-1 (HNF4A Mutation)
por: Broome, David Tyler, et al.
Publicado: (2020)

SUN-679 Early Onset Diabetes Mellitus in a Young Woman with Ring Chromosome 13 Syndrome
por: Buehler, Lauren Anne, et al.
Publicado: (2020)

OR05-6 The Effect of the GLP1R Variant rs6923761 on Post-Prandial Glucose Levels during Treatment with Sitagliptin
por: Mashayekhi, Mona, et al.
Publicado: (2019)

PSUN276 GLP1RAs use for treating NALFD in a multidisciplinary clinic in low socioeconomic community
por: West, Brittany, et al.
Publicado: (2022)

MON-130 Optimal Glycemic Control in a Patient with HNF1A MODY with GLP1-RA Monotherapy: Implications for Future Therapy
por: Fantasia, Kathryn, et al.
Publicado: (2019)

Efficient Restoration of Beta Cell Dedifferentiation by Calorie Restriction With High Fat/Low Carbohydrate Diet in Obese Diabetes Model and the Possible Role of GLP-1
por: Ishida, Emi, et al.
Publicado: (2021)

FRI639 Effect Of Early Initiation Of GLP-1 RAs On Weight Reduction Among People With Type 2 Diabetes
por: Chinthammit, Chanadda, et al.
Publicado: (2023)

SAT-662 Effects of SGLT Inhibitors or GLP1 Analogues on Glucose Homeostasis and Body Weight in Patients with Type 1 Diabetes: A Network Meta-Analysis
por: Lim, Soo, et al.
Publicado: (2020)

SUN-165 The Largest Single-Center Experience of GLP-1 Receptor Agonists as a Safe and Effective Agent for the Management of Diabetes in Solid Organ Transplant (SOT) Recipients
por: Singh, Priyamvada, et al.
Publicado: (2019)

SAT-635 Results of a Preclinical Pilot Study Evaluating 24-Hour Subcutaneous Infusion of the GLP-1 Analogue Liraglutide Delivered via the H-Patch Wearable Device
por: Barnes, Jessica W, et al.
Publicado: (2020)

SUN-698 Management of Hyperglycemia in an Adult Patient with Glycogen Storage Disease Type 1b
por: Mikhael, Alexandra, et al.
Publicado: (2020)

SUN-663 Dietary Coconut Oil Mitigates Features of Metabolic Syndrome in Obese Females
por: Skenandore, Cassandra, et al.
Publicado: (2020)

The Use of Omnipod® 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes With Suboptimal Glycemic Management: From Injections to Closed-Loop Therapy
por: Bode, Bruce W, et al.
Publicado: (2021)

Accuracy of a Point-of Care Hemoglobin A1c Assay - A Community Outreach Project
por: Semreen, Noura, et al.
Publicado: (2021)

SAT-144 Can Point-of-Care Betahydroxybutyrate Testing Be Used to Predict Diabetic Ketoacidosis in the Pediatric Emergency Department?
por: Knoll, Michelle, et al.
Publicado: (2019)

MON-618 A Framework for Understanding and Managing ‘The Diabetes Syndrome’: A Unified Pathophysiologic Approaching the Context of the Beta-Cell Classification of Diabetes
por: Schwartz, Stanley S
Publicado: (2020)

Definition of Norma / Prediabetes Cut-off Point for Fasting Glycaemia on the Basis of Glucose Tolerance Test and HbA1c Interrelationships
por: Ismayilova, Sevil, et al.
Publicado: (2021)

SAT-171 Effective Intrajejunal Wall Delivery of Recombinant Human Insulin via a Self-Deployed Ingestible Capsule in Anesthetized Swines: A Pharmacokinetic and Pharmacodynamic Study
por: Hashim, Mir, et al.
Publicado: (2019)

OR22-2 Exposure to Hypoglycemia in Older Adults with Type 1 Diabetes: Baseline Characteristics Using Continuous Glucose Monitoring Data
por: Carlson, Anders, et al.
Publicado: (2019)

Online CME Successful at Improving Awareness, Understanding, and Clinical Use of T2D Treatments
por: Larkin, Amy, et al.
Publicado: (2021)

Euglycemic Diabetic Ketoacidosis Secondary to SGLT2-inhibitor Use in Combination With a Ketogenic Diet
por: Hester, Joi C, et al.
Publicado: (2021)

Clinical Practice Gap Analysis of CKD in T2D From Identification to Diagnosis to Management
por: Larkin, Amy, et al.
Publicado: (2021)

SAT-131 Success of CME/CE in Promoting Practice Improvements in the Use of New Technologies for Glucose Monitoring
por: Larkin, Amy, et al.
Publicado: (2019)

SAT-643 Predictors of Technology Success in Cystic Fibrosis Related Diabetes
por: Jain, Ashna, et al.
Publicado: (2020)

SUN-687 MODY-14: A Rare Cause of Inherited Diabetes
por: Epp, Riley, et al.
Publicado: (2020)

Online Education Improves Knowledge and Confidence Related to CGM and the AGP
por: Larkin, Amy, et al.
Publicado: (2021)

The Troublesome Triad: Hypertriglyceridemia-Induced Acute Pancreatitis in Diabetic Ketoacidosis
por: Rashid, Hytham, et al.
Publicado: (2021)

Severe, New-Onset Diabetes Mellitus Triggered by COVID-19 Infection Followed by Euglycemia Upon Recovery: A Case Report
por: Yu, Ian, et al.
Publicado: (2021)

OR14-6 The Role of the Angiopoietin-Tie2 Pathway in Microvascular Complications of Diabetes Mellitus
por: Brigell, Mitchell, et al.
Publicado: (2019)

MON-LB029 The Influence of SGLT-2 Inhibitors and Other Glucose-Lowering Therapies on All-Cause Mortality Risk and Cardiovascular Outcomes in Older Patients with Newly Treated Type 2 Diabetes: A Population-Based Cohort Study
por: Doyle, Mary-Anne, et al.
Publicado: (2019)

Renal GLUT2 is Essential in Regulating Systemic Glucose Homeostasis by Glycosuria
por: de Souza Cordeiro, Leticia M, et al.
Publicado: (2021)

THU264 Enteric Activity Enhanced Ileal GLP-1 Secretion
por: Chen, Yixin, et al.
Publicado: (2023)

SUN-616 Poor Diagnostic Concordance Between Fasting Plasma Glucose and Glycosylated Hemoglobin in a Black South African Population
por: Wade, Alisha N, et al.
Publicado: (2020)

THU263 Intestinal Production of H(2)S And Its Regulation Of GLP-2
por: Hammond, Joel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ujbn7rdic8iuel7gncopumrhm6